WARD 24/7 Secures €3.4 Million in Funding
WARD 24/7, a Copenhagen, Denmark-based startup that specializes in AI-based patient monitoring technology, has achieved the CE marking and secured approximately €3.4 million (DKK 23 million) in funding.
WARD 24/7, a Copenhagen, Denmark-based startup that specializes in AI-based patient monitoring technology, has achieved the CE marking and secured approximately €3.4 million (DKK 23 million) in funding.
SaaS Investors
Investors in this round include Innovestor, Sagitta Ventures, and the Export and Investment Fund of Denmark (EIFO), with EIFO.
WARD 24/7 Use of Funds
The funding will support the startup's expansion efforts and the implementation of its AI technology in the healthcare sector.
WARD 24/7 aims to enhance overall healthcare efficiency by streamlining tasks, reducing complications, and improving patient care through its digital patient monitoring system.
About WARD 24/7
Established in 2016, WARD 24/7 focuses on easing the workload for healthcare professionals and improving patient care. Their digital patient monitoring system aims to streamline tasks, reduce complications, and enhance overall healthcare efficiency, addressing vital needs in the industry. WARD's 24/7 core focus is on developing innovative solutions that leverage artificial intelligence to monitor patients’ vital signs, such as heart and lung functions. The company’s recent achievement of obtaining the CE marking certifies that its AI technology meets the stringent standards required for medical equipment in the EU.
Funding Details
Company: WARD 24/7 ApS
Raised: €3.4M
Round: Unknown
Funding Month: January 2024
Investors: Innovestor, Sagitta Ventures, and the Export and Investment Fund of Denmark (EIFO)
Company Website: https://ward247.com/
Software Category: AI Patient Monitoring
